Emerging Technologies in Drug Discovery for Providing Efficient Services to Patients: Future Opportunities and Challenges

Emerging Technologies in Drug Discovery for Providing Efficient Services to Patients: Future Opportunities and Challenges

V. Hemamalini, M. Jeyaselvi, S. Savitha, Amit Kumar Tyagi
DOI: 10.4018/979-8-3693-2897-2.ch009
OnDemand:
(Individual Chapters)
Available
$37.50
No Current Special Offers
TOTAL SAVINGS: $37.50

Abstract

This chapter examines the current landscape and future prospects of emerging technologies in drug discovery, focusing on their potential to provide efficient and innovative services to patients. The integration of technologies such as artificial intelligence (AI), machine learning, high-throughput screening, and advanced analytics is reshaping the drug discovery process, promising accelerated development timelines and improved therapeutic outcomes. AI and machine learning algorithms play a pivotal role in data analysis, aiding in the identification of potential drug candidates, target validation, and predictive modeling. High-throughput screening technologies enable the rapid testing of large compound libraries, expediting the identification of lead compounds and optimizing drug development pipelines. Additionally, advanced analytics facilitate the interpretation of complex biological data, enhancing our understanding of disease mechanisms and drug interactions. The convergence of these technologies holds immense promise for personalized medicine.
Chapter Preview
Top

Role Of Emerging Technologies In Drug Discovery

Emerging technologies play a pivotal role in revolutionizing the landscape of drug discovery, providing novel approaches to identify, design, develop, and deliver therapeutic interventions (Brown, D.G, et al., 2006). These technologies use advances in various scientific disciplines, computational power, and data analytics to accelerate the drug discovery process and enhance its efficiency. Here are some key roles of emerging technologies in drug discovery:

Target Identification and Validation: Genomics, proteomics, and bioinformatics enable the identification and validation of disease-related targets with unprecedented speed and accuracy. High-throughput sequencing technologies, for instance, allow researchers to analyze vast amounts of genetic data to pinpoint genetic variations associated with diseases, facilitating the identification of novel drug targets.

Complete Chapter List

Search this Book:
Reset